We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer and BioNTech Kick Off Study Evaluating Booster Shot Against South African Variant
Pfizer and BioNTech Kick Off Study Evaluating Booster Shot Against South African Variant
Pfizer and BioNTech have begun assessing the safety and immunogenicity of a third dose of their COVID-19 vaccine against the coronavirus’ South African mutation and other potential viral variants.